Standard
Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy. / Bruusgaard-Mouritsen, Maria A.; Koo, Grace; Heinrichsen, Anne Sophie; Melchiors, Birgitte Bech; Krantz, Matthew S.; Plager, Jessica H.; Boxer, Mitchell; Phillips, Elizabeth J.; Stone, Cosby A.; Garvey, Lene H.
In:
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, No. 3, 2022, p. 859-862.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Bruusgaard-Mouritsen, MA, Koo, G, Heinrichsen, AS, Melchiors, BB, Krantz, MS, Plager, JH, Boxer, M, Phillips, EJ, Stone, CA
& Garvey, LH 2022, '
Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy',
Journal of Allergy and Clinical Immunology: In Practice, vol. 10, no. 3, pp. 859-862.
https://doi.org/10.1016/j.jaip.2021.12.025APA
Bruusgaard-Mouritsen, M. A., Koo, G., Heinrichsen, A. S., Melchiors, B. B., Krantz, M. S., Plager, J. H., Boxer, M., Phillips, E. J., Stone, C. A.
, & Garvey, L. H. (2022).
Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy.
Journal of Allergy and Clinical Immunology: In Practice,
10(3), 859-862.
https://doi.org/10.1016/j.jaip.2021.12.025Vancouver
Bruusgaard-Mouritsen MA, Koo G, Heinrichsen AS, Melchiors BB, Krantz MS, Plager JH et al.
Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy.
Journal of Allergy and Clinical Immunology: In Practice. 2022;10(3):859-862.
https://doi.org/10.1016/j.jaip.2021.12.025Author
Bruusgaard-Mouritsen, Maria A. ; Koo, Grace ; Heinrichsen, Anne Sophie ; Melchiors, Birgitte Bech ; Krantz, Matthew S. ; Plager, Jessica H. ; Boxer, Mitchell ; Phillips, Elizabeth J. ; Stone, Cosby A. ; Garvey, Lene H. / Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy. In: Journal of Allergy and Clinical Immunology: In Practice. 2022 ; Vol. 10, No. 3. pp. 859-862.
Bibtex
@article{a91ed7a363414485abae93fc80c19dd3,
title = "Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy",
author = "Bruusgaard-Mouritsen, {Maria A.} and Grace Koo and Heinrichsen, {Anne Sophie} and Melchiors, {Birgitte Bech} and Krantz, {Matthew S.} and Plager, {Jessica H.} and Mitchell Boxer and Phillips, {Elizabeth J.} and Stone, {Cosby A.} and Garvey, {Lene H.}",
note = "Funding Information: C.A.S. receives funding from the Agency for Healthcare Research and Quality/Patient-Centered Outcomes Research Institute (grant no. 1K12HS026395-01) and the American Academy of Allergy, Asthma & Immunology Foundation. E.G.P. reports direct support as a principal investigator from the National Institutes of Health (NIH; grant nos. R01HG010863, R01AI152183, U01AI154659, UAI109565, and R13AR078623) as well as other coinvestigator support from the NIH and the National Health and Medical Research Foundation of Australia. Funding Information: C.A.S. receives funding from the Agency for Healthcare Research and Quality/ Patient-Centered Outcomes Research Institute (grant no. 1K12HS026395-01 ) and the American Academy of Allergy, Asthma & Immunology Foundation . E.G.P. reports direct support as a principal investigator from the National Institutes of Health (NIH; grant nos. R01HG010863 , R01AI152183 , U01AI154659 , UAI109565 , and R13AR078623 ) as well as other coinvestigator support from the NIH and the National Health and Medical Research Foundation of Australia . ",
year = "2022",
doi = "10.1016/j.jaip.2021.12.025",
language = "English",
volume = "10",
pages = "859--862",
journal = "The Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
publisher = "Elsevier",
number = "3",
}
RIS
TY - JOUR
T1 - Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy
AU - Bruusgaard-Mouritsen, Maria A.
AU - Koo, Grace
AU - Heinrichsen, Anne Sophie
AU - Melchiors, Birgitte Bech
AU - Krantz, Matthew S.
AU - Plager, Jessica H.
AU - Boxer, Mitchell
AU - Phillips, Elizabeth J.
AU - Stone, Cosby A.
AU - Garvey, Lene H.
N1 - Funding Information:
C.A.S. receives funding from the Agency for Healthcare Research and Quality/Patient-Centered Outcomes Research Institute (grant no. 1K12HS026395-01) and the American Academy of Allergy, Asthma & Immunology Foundation. E.G.P. reports direct support as a principal investigator from the National Institutes of Health (NIH; grant nos. R01HG010863, R01AI152183, U01AI154659, UAI109565, and R13AR078623) as well as other coinvestigator support from the NIH and the National Health and Medical Research Foundation of Australia.
Funding Information:
C.A.S. receives funding from the Agency for Healthcare Research and Quality/ Patient-Centered Outcomes Research Institute (grant no. 1K12HS026395-01 ) and the American Academy of Allergy, Asthma & Immunology Foundation . E.G.P. reports direct support as a principal investigator from the National Institutes of Health (NIH; grant nos. R01HG010863 , R01AI152183 , U01AI154659 , UAI109565 , and R13AR078623 ) as well as other coinvestigator support from the NIH and the National Health and Medical Research Foundation of Australia .
PY - 2022
Y1 - 2022
U2 - 10.1016/j.jaip.2021.12.025
DO - 10.1016/j.jaip.2021.12.025
M3 - Journal article
C2 - 34979336
AN - SCOPUS:85123076241
VL - 10
SP - 859
EP - 862
JO - The Journal of Allergy and Clinical Immunology: In Practice
JF - The Journal of Allergy and Clinical Immunology: In Practice
SN - 2213-2198
IS - 3
ER -
